Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,115 hedge funds and large institutions have $67.3B invested in Allergan plc in 2017 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 467 increasing their positions, 409 reducing their positions, and 79 closing their positions.
28% more first-time investments, than exits
New positions opened: 101 | Existing positions closed: 79
14% more repeat investments, than reductions
Existing positions increased: 467 | Existing positions reduced: 409
9% more call options, than puts
Call options by funds: $2.21B | Put options by funds: $2.03B
1% more funds holding
Funds holding: 1,104 → 1,115 (+11)
2% less capital invested
Capital invested by funds: $68.4B → $67.3B (-$1.09B)
5% less funds holding in top 10
Funds holding in top 10: 77 → 73 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$1.14B |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$373M |
| 3 |
JP Morgan Chase
New York
|
+$295M |
| 4 |
Edgewood Management
Greenwich,
Connecticut
|
+$205M |
| 5 |
SIG
Senator Investment Group
New York
|
+$141M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$761M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$740M |
| 3 |
Goldman Sachs
New York
|
-$336M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$200M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$194M |
AGN Hedge Fund Activity: Q2 2017 in Review
1,115 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2017, worth a combined $67.3B — down 1.6% from $68.4B a quarter earlier.
Buyers outnumbered sellers: 101 funds opened new AGN positions and 79 closed out — a net gain of 22 holders — while 467 added to existing stakes and 409 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $1.14B. The largest seller was Veritas Asset Management, exiting entirely with an estimated $761M sold.
- 1,115 institutional investors held Allergan plc (AGN) as of Q2 2017, up from 1,104 in Q1 2017.
- Funds reported $67.3B of Allergan plc stock for Q2 2017, down 1.6% quarter-over-quarter.
- 101 funds opened new Allergan plc positions in Q2 2017 and 79 closed out, a net change of +22 holders.
- The largest Allergan plc buyer in Q2 2017 was Janus Henderson Group, an estimated $1.14B added.
- The largest Allergan plc seller in Q2 2017 was Veritas Asset Management, an estimated $761M sold.
Based on aggregated 13F filings for Q2 2017.